Does the media refer more to FMS or LH?

In the previous week, Labcorp had 14 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 19 mentions for Labcorp and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Labcorp's score of 0.73 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Labcorp 6 Very Positive mention(s) 5 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or FMS?

In the previous week, Tempus AI had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for Tempus AI and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Tempus AI's score of 0.74 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

$21.56 +0.15 (+0.68%)

Closing price 10/21/2026 03:59 PM Eastern

Extended Trading

$21.58 +0.02 (+0.11%)

As of 07:39 AM Eastern

Compare

FMS vs. DGX, LH, GH, TEM, and BTSG

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? Fresenius Medical Care AG & Co. KGaA's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Tempus AI (TEM), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Quest Diagnostics has a net margin of 9.18% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Quest Diagnostics' return on equity of 16.01% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Quest Diagnostics	9.18%	16.01%	7.27%

Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.8%. Quest Diagnostics pays an annual dividend of $3.44 per share and has a dividend yield of 1.4%. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Quest Diagnostics pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has increased its dividend for 14 consecutive years. Fresenius Medical Care AG & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Quest Diagnostics had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for Quest Diagnostics and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Quest Diagnostics' score of 0.55 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quest Diagnostics	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.43, suggesting a potential upside of 8.67%. Quest Diagnostics has a consensus price target of $243.64, suggesting a potential upside of 2.03%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.64
Quest Diagnostics	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.50

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Quest Diagnostics. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.52	$1.11B	$1.93	11.17
Quest Diagnostics	$11.04B	2.39	$992M	$9.42	25.35

Summary

Quest Diagnostics beats Fresenius Medical Care AG & Co. KGaA on 13 of the 20 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Labcorp (NYSE:LH) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

In the previous week, Labcorp had 14 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 19 mentions for Labcorp and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Labcorp's score of 0.73 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Labcorp	6 Very Positive mention(s)	5 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.8%. Labcorp pays an annual dividend of $2.88 per share and has a dividend yield of 0.9%. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Labcorp pays out 23.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Labcorp has a net margin of 6.99% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Labcorp's return on equity of 16.74% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Labcorp	6.99%	16.74%	7.81%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Labcorp. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.52	$1.11B	$1.93	11.17
Labcorp	$13.95B	1.88	$876.50M	$12.09	26.75

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.43, indicating a potential upside of 8.67%. Labcorp has a consensus price target of $337.73, indicating a potential upside of 4.43%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.64
Labcorp	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Labcorp has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 0.8% of Labcorp shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Labcorp beats Fresenius Medical Care AG & Co. KGaA on 13 of the 18 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

In the previous week, Guardant Health had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 21 mentions for Guardant Health and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Guardant Health's score of 0.55 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health currently has a consensus target price of $190.00, indicating a potential upside of 14.00%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.43, indicating a potential upside of 8.67%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.64

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Guardant Health has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	22.78	-$416.28M	-$3.49	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.52	$1.11B	$1.93	11.17

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	8.54	-$245.03M	-$1.44	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.52	$1.11B	$1.93	11.17

In the previous week, Tempus AI had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for Tempus AI and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.81 beat Tempus AI's score of 0.74 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Tempus AI's net margin of -17.77%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tempus AI presently has a consensus price target of $72.37, suggesting a potential upside of 6.80%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.43, suggesting a potential upside of 8.67%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.64

Tempus AI has a beta of 3.54, meaning that its stock price is 254% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Tempus AI on 9 of the 16 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
BrightSpring Health Services	2.55%	16.73%	5.24%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.52	$1.11B	$1.93	11.17
BrightSpring Health Services	$14.37B	0.86	$190.67M	$1.66	37.57

Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

In the previous week, Fresenius Medical Care AG & Co. KGaA had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 5 mentions for Fresenius Medical Care AG & Co. KGaA and 3 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.12 beat Fresenius Medical Care AG & Co. KGaA's score of 0.81 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $23.43, suggesting a potential upside of 8.67%. BrightSpring Health Services has a consensus target price of $72.88, suggesting a potential upside of 16.86%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.64
BrightSpring Health Services	0 Sell rating(s)	2 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.95

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FMS vs. The Competition

Export

Metric	Fresenius Medical Care AG & Co. KGaA	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.50B	$10.74B	$7.59B	$23.32B
Dividend Yield	2.83%	2.58%	2.49%	3.71%
P/E Ratio	8.05	29.84	216.34	25.18
Price / Sales	0.52	5.62	587.96	13.03
Price / Cash	3.85	112.10	76.45	34.21
Price / Book	0.75	5.19	10.76	4.74
Net Income	$1.11B	$320.54M	$3.51B	$1.07B
7 Day Performance	-2.48%	-0.01%	0.31%	-0.14%
1 Month Performance	-4.32%	-3.72%	-8.00%	-2.53%
1 Year Performance	-21.36%	16.28%	4.51%	6.63%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FMS Fresenius Medical Care AG & Co. KGaA	3.6853 of 5 stars	$21.56 +0.7%	$23.43 +8.7%	-20.5%	$11.50B	$22.20B	8.05	1,488
DGX Quest Diagnostics	4.5003 of 5 stars	$232.58 +0.7%	$237.85 +2.3%	+29.4%	$25.49B	$11.04B	24.69	57,000	Analyst Forecast
LH Labcorp	4.0811 of 5 stars	$315.17 +1.0%	$337.73 +7.2%	+13.9%	$25.32B	$13.95B	26.07	71,000	News Coverage Upcoming Earnings Dividend Announcement Analyst Upgrade
GH Guardant Health	2.5781 of 5 stars	$162.79 -2.8%	$190.00 +16.7%	+146.9%	$22.47B	$982.02M	N/A	2,506
TEM Tempus AI	2.7912 of 5 stars	$67.99 -4.1%	$71.84 +5.7%	-24.0%	$12.80B	$1.43B	N/A	3,800

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 10/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. DGX, LH, GH, TEM, and BTSG

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. DGX, LH, GH, TEM, and BTSG

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Is FMS or DGX more profitable?

Which has more risk and volatility, FMS or DGX?

Do institutionals and insiders believe in FMS or DGX?

Is FMS or DGX a better dividend stock?

Does the media prefer FMS or DGX?

Do analysts prefer FMS or DGX?

Which has better earnings & valuation, FMS or DGX?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Does the media refer more to FMS or LH?

Is FMS or LH a better dividend stock?

Is FMS or LH more profitable?

Which has stronger valuation and earnings, FMS or LH?

Do analysts recommend FMS or LH?

Which has more risk & volatility, FMS or LH?

Do institutionals and insiders hold more shares of FMS or LH?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Does the media prefer GH or FMS?

Do analysts recommend GH or FMS?

Is GH or FMS more profitable?

Which has more volatility & risk, GH or FMS?

Do institutionals & insiders believe in GH or FMS?

Which has better earnings & valuation, GH or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Which has stronger valuation & earnings, TEM or FMS?

Does the media prefer TEM or FMS?

Is TEM or FMS more profitable?

Do insiders & institutionals have more ownership in TEM or FMS?

Do analysts rate TEM or FMS?

Which has more risk & volatility, TEM or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Is FMS or BTSG more profitable?

Do institutionals and insiders hold more shares of FMS or BTSG?

Which has preferable earnings and valuation, FMS or BTSG?

Which has more volatility & risk, FMS or BTSG?

Does the media favor FMS or BTSG?

Do analysts rate FMS or BTSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools